Syneron Medical announced that its proprietary Sublative technology has received CE Mark indication for the effective treatment of striae (stretch marks) and acne scars.
With its new CE Mark clearance, Sublative has been shown to be an effective and safe way to reduce the appearance of stretch marks, acne scars and other skin irregularities in all skin types with minimal side effects, discomfort or downtime.
The patented technology uses fractionated bi-polar radiofrequency directed to the skin in the form of a matrix, which is deposited in the skin to initiate a healing response with minimal epidermal disruption.
After treatment with Sublative, the appearance of stretch marks and acne scars are greatly reduced.
The Sublative protocol consists of three to five treatments, spaced four to six weeks apart. Post treatment, patients can expect tone and texture improvements as a result of increased levels of collagen and elastin and new healthy skin cells, which are produced.
The addition of stretch mark treatment further expands Syneron’s clinical utility and will allow physician customers to address a large segment of the aesthetic market.
Syneron CEO Amit Meridor said the company has received very positive physician and patient feedback on the Sublative technology since its introduction in 2009.
"This patented fractional bi-polar radio frequency technology delivers excellent outcomes with little-to-no downtime and is a safe and more effective treatment alternative for all skin tones," Meridor added.
"We continue to create innovation solutions that further drive the aesthetic industry forward."
The new treatment protocols are now available on all of the Syneron Sublative compatible systems, which include elos Plus, eTwo and eMatrix.
The company said it will unveil the Striae and acne scars treatment protocols for its Sublative compatible platforms at the 12th Annual Anti-Aging Medicine World Congress in Monte Carlo, Monaco from April 3-5, 2014.